PD-013RAS mutations in circulating tumor DNA (ctDNA) and clinical outcomes of rechallenge treatments with anti-EGFR antibodies in patients with metastatic colorectal cancer (mCRC)
Sunakawa, Y, Nakamura, M, Ishizaki, M, Kataoka, M, Satake, H, Kitazono, M, Yanagisawa, H, Kawamoto, Y, Kuramochi, H, Ohori, H, Nakamura, M, Takahashi, K, Maeda, F, Komeno, C, Takeuchi, M, Fujii, M, YoVolume:
30
Journal:
Annals of Oncology
DOI:
10.1093/annonc/mdz156.012
Date:
July, 2019
Fichier:
PDF, 75 KB
2019
File converter
Plus de résultats de recherche
More benefits 
